No Data
Wall Street Set to Open Lower Thursday; Weekly Initial Jobless Claims Rise Higher Than Expected
Sector Update: Health Care Stocks Edge Higher Premarket Thursday
Express News | ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%
ANI Pharmaceuticals Is Maintained at Outperform by Raymond James
Raymond James Initiates ANI Pharmaceuticals(ANIP.US) With Buy Rating, Announces Target Price $83
In-Depth Examination Of 4 Analyst Recommendations For ANI Pharmaceuticals
ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Shareholders Respectable 19% CAGR Over 3 Years, Surging 5.9% in the Last Week AloneNo Data
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}